Founded in 2016, Qure.ai is on a mission to make healthcare more accessible and equitable globally. This has driven its AI solution development, positioning the company as the world's most deployed healthcare AI. Qure.ai solutions are deployed in over 90 countries across 3000+ sites, powering the efficient identification and management of critical diseases. The company has 18 FDA-cleared indications, and its products are Class IIb certified per EU MDR* regulations.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/25/24 | $65,000,000 | Series D |
360 ONE Asset HealthQuad Kae Capital Lightspeed Venture Partners Merck Global Health Innovation Fund Novo Holdings TeamFund | undisclosed |
